Skip to content

Management of Prostate Cancer in Central China

Comparisons of Management and Outcome of Prostate Cancer in Central China Between 2003 and 2008: A Multi-institutional Report

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01614548
Enrollment
789
Registered
2012-06-08
Start date
2003-01-31
Completion date
2011-12-31
Last updated
2012-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostatic Neoplasms, Prostate Cancer, Disease Management, Rural, Urban

Brief summary

Some recent reports indicate that incidence of prostate cancer is increasing rapidly in China. However, no large-scale survey of prostate cancer has been done in central China, few data are available regarding its management. The investigators aimed to analyze the management of prostate cancer and compare the outcome of patients with such a survey. The investigators collected data of patients diagnosed with prostate cancer from the 2003 and 2008 in central China. Data were disaggregated by rural and urban hukou. The survival rate of patients was analyzed using Kaplan-Meier method. Prognostic factors were analyzed using the log-rank test and Cox proportional hazards model.

Interventions

None listed

Sponsors

The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
the cancer hospital of Zhengzhou University
CollaboratorUNKNOWN
Third Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
People's Hospital of Zhengzhou University
CollaboratorOTHER
Xinyang Central Hospital
CollaboratorOTHER
Zhoukou Central Hospital
CollaboratorOTHER
Center hospital of Nanyang
CollaboratorUNKNOWN
Center hospital of Shangqiu
CollaboratorUNKNOWN
Zhumadian Central Hospital
CollaboratorOTHER
Anyang Regional Hospital
CollaboratorOTHER
Luoyang Central Hospital
CollaboratorOTHER
First People's Hospital of Kaifeng
CollaboratorOTHER
Zhengzhou University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* patients with newly diagnosed prostate cancer were included in the study.

Exclusion criteria

* Those with a history of prostate cancer who were treated for another disease were excluded from study.

Design outcomes

Primary

MeasureTime frameDescription
overall survival3 yearsoverall survival that was defined as the interval from the date of diagnosis to the Medicare date of death

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026